[Hormonal regulation and hormone therapy in childhood and adolescence. Part 2: Therapeutic problems (tall stature, amenorrhea, delayed puberty, oligomenorrhea, precocious puberty, anorexia nervosa, anisomastia, hypermastia, acne etc)].
The most important therapeutic problems of female puberty and adolescence are discussed, including high stature, amenorrhoea, oligomenorrhea, pubertas tarda, anovulation, anorexia, anisomastia, hypermastia. Indications for treatment are given and the possibilities for a prophylactic medicine in this age group are stressed.
D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000568:Amenorrhea / Q000188:drug therapy; D000856:Anorexia Nervosa / Q000188:drug therapy*; D001941:Breast Diseases / Q000601:surgery; D002648:Child; D003534:Cyproterone / Q000627:therapeutic use; D004338:Drug Combinations; D004700:Endocrine System Diseases / Q000188:drug therapy*; D045166:Estradiol Congeners / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy*; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy*; D009765:Obesity / Q000517:prevention & control; D009839:Oligomenorrhea / Q000188:drug therapy; D045167:Progesterone Congeners / Q000627:therapeutic use*; D011629:Puberty, Precocious / Q000188:drug therapy
D004338:Drug Combinations; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; D003534:Cyproterone
Hormonale Regulation und Hormontherapie im Kindes- und Jugendalter. Teil 2: Therapeutische Probleme (Hochwuchs, Amenorrhoe, Pubertas tarda, Anovulation oder Oligomenorrhoe, Pubertas praecox, Anorexia mentalis, Anisomastie, Hypermastie, Akne u.a.).